Evotec Appoints Dr Ingrid Müller as Chief Operating Officer
Renaissance Pharma secures FDA Fast Track Designation and IND clearance for Daretabart in high-risk neuroblastoma
AbbVie’s Elahere succeeds in phase 2 platinum-sensitive ovarian cancer trial
Cell line development market to reach $8.95 billion by 2031 with Gene & Cell Therapy manufacturing growing at 10.88%
Global Drug Delivery and Formulation (DDF) Summit
Chemspec Europe reveals new details about 2026 conference programme
Inaugural International Brain Health Conference 2026 to focus on early intervention before dementia
Major growth in visitor numbers, full halls, clear future topics: Analytica 2026 sets standards
Interphex week Tokyo 2026 conference programme announced
